Scholar Rock Holding SRRK
NASDAQ SRRK
$46.81 +0.65 (+1.41%)
At close: Oct 2, 2026 · 4:00 PM EDT

Scholar Rock Holding (SRRK) Selling, General & Administrative (2017 - 2026)

Updated

Scholar Rock Holding (SRRK) reported Selling, General & Administrative of $50.67 million for Q2 2026, up 1.9% from $49.71 million a year earlier and up 0.9% from the prior quarter.

Analysis

Scholar Rock Holding (SRRK) Selling, General & Administrative (2017 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Scholar Rock Holding's Selling, General & Administrative came in at $198.95 million, up 75.8% year-over-year; for FY2025, it came in at $176.21 million, up 161.0% from FY2024.

  • Selling, General & Administrative has increased for eight consecutive years, with a five-year compound annual growth rate of 44.2% (FY2020 to FY2025).
  • By year, Selling, General & Administrative came in at $67.5 million in FY2024 (+36.7%), $49.4 million in FY2023 (+14.6%), $43.12 million in FY2022 (+7.1%) and $40.27 million in FY2021 (+42.7%).
  • Five-year quarterly Selling, General & Administrative spans a low of $10.36 million in Q4 2021 and a high of $53.06 million in Q3 2025.
  • Year over year, Selling, General & Administrative has now increased in each of the last 15 quarters, with growth averaging 98.4% over the last eight quarters.
  • The high point for year-over-year Selling, General & Administrative in five years was Q3 2025 (growth of 230.4%); the low point was Q3 2022 (a decline of 7.1%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $50.2 million (Q1 2026), $45.02 million (Q4 2025) and $53.06 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Scholar Rock Holding 5.69 Bn 5.69 Bn - 50.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 50.67 Mn
Mar 31, 2026 50.20 Mn
Dec 31, 2025 45.02 Mn
Sep 30, 2025 53.06 Mn
Jun 30, 2025 49.71 Mn
Mar 31, 2025 28.41 Mn
Dec 31, 2024 18.99 Mn
Sep 30, 2024 16.06 Mn
Jun 30, 2024 17.13 Mn
Mar 31, 2024 15.33 Mn
Dec 31, 2023 13.07 Mn
Sep 30, 2023 13.34 Mn
Jun 30, 2023 12.22 Mn
Mar 31, 2023 10.77 Mn
Dec 31, 2022 10.82 Mn
Sep 30, 2022 10.47 Mn
Jun 30, 2022 11.07 Mn
Mar 31, 2022 10.76 Mn
Dec 31, 2021 10.36 Mn
Sep 30, 2021 11.28 Mn
API Access

Scholar Rock Holding Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SRRK&period=max&api_key=YOUR_API_KEY